Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache
Standard
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. / Schoenen, Jean; Snoer, Agneta Henriette; Brandt, Roemer B; Fronczek, Rolf; Wei, Diana Y; Chung, Chin-Sang; Diener, Hans-Christoph; Dodick, David W; Fontaine, Denys; Goadsby, Peter J; Matharu, Manjit Singh; May, Arne; McGinley, James S; Tepper, Stewart J; Jensen, Rigmor Højland; Ferrari, Michel D; IHS Standing Committee for Clinical Trials.
in: CEPHALALGIA, Jahrgang 42, Nr. 14, 12.2022, S. 1450-1466.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache
AU - Schoenen, Jean
AU - Snoer, Agneta Henriette
AU - Brandt, Roemer B
AU - Fronczek, Rolf
AU - Wei, Diana Y
AU - Chung, Chin-Sang
AU - Diener, Hans-Christoph
AU - Dodick, David W
AU - Fontaine, Denys
AU - Goadsby, Peter J
AU - Matharu, Manjit Singh
AU - May, Arne
AU - McGinley, James S
AU - Tepper, Stewart J
AU - Jensen, Rigmor Højland
AU - Ferrari, Michel D
AU - IHS Standing Committee for Clinical Trials
PY - 2022/12
Y1 - 2022/12
N2 - In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.
AB - In 1995, a committee of the International Headache Society developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Cluster Headache. These have not been revised. With the emergence of new medications, neuromodulation devices and trial designs, an updated version of the International Headache Society Guidelines for Controlled Clinical Trials in Cluster Headache is warranted. Given the scarcity of evidence-based data for cluster headache therapies, the update is largely consensus-based, but takes into account lessons learned from recent trials and demands by patients. It is intended to apply to both drug and neuromodulation treatments, with specific proposals for the latter when needed. The primary objective is to propose a template for designing high quality, state-of-the-art, controlled clinical trials of acute and preventive treatments in episodic and chronic cluster headache. The recommendations should not be regarded as dogma and alternative solutions to particular methodological problems should be explored in the future and scientifically validated.
KW - Humans
KW - Cluster Headache/drug therapy
KW - Headache/therapy
KW - Controlled Clinical Trials as Topic
U2 - 10.1177/03331024221120266
DO - 10.1177/03331024221120266
M3 - Other (editorial matter etc.)
C2 - 36268950
VL - 42
SP - 1450
EP - 1466
JO - CEPHALALGIA
JF - CEPHALALGIA
SN - 0333-1024
IS - 14
ER -